FDA finalizes recommendations simplifying approval process for medical devices that use AI
The Food and Drug Administration yesterday released for streamlining the approval process for medical devices that use artificial intelligence. The guidance recommends information to include in a predetermined change control plan as part of a marketing submission for a medical device using AI. The PCCP should include a description of the device's planned modifications; methods to develop, validate and implement the modifications; and an assessment of the modification's impacts. FDA will then review the PCCP within the submission to ensure the device's safety and effectiveness without needing additional marketing submissions for each modification.
Related News Articles
Headline
Cleveland Clinic's Eric Boose, M.D., family medicine physician and associate chief medical information officer and Rohit Chandra, executive vice president and…
Headline
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in…
Perspective
America’s hospitals and health systems are incubators of innovation, ideas and medical progress as they are constantly striving to improve patient care and…
Headline
A ChatGPT vulnerability identified last year is being used by cyberthreat actors to attack security flaws in artificial intelligence systems, according to a…
Headline
In this conversation, Dave Newman, M.D., vice president and chief medical officer for virtual care at Sanford Health, discusses how innovative virtual care…
Headline
The AHA participated Feb. 18 at ViVE, a health care conference in Nashville focusing on digital health technology. Chris DeRienzo, M.D., AHA senior vice…